Related Experiment Video
Updated: May 27, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Inhibitory effect of aqueous Dandelion extract on HIV-1 replication and reverse transcriptase activity
1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, PR China.
BMC Complementary and Alternative Medicine
|November 15, 2011
Summary
Aqueous dandelion extract shows potent activity against HIV-1 replication and reverse transcriptase activity. This natural product may offer a new avenue for developing antiretroviral therapies with fewer side effects.
Area of Science:
- Natural Product Chemistry
- Virology
- Immunology
Background:
- Acquired immunodeficiency syndrome (AIDS) is caused by human immunodeficiency virus (HIV), leading to opportunistic infections.
- Current HIV therapies face challenges like drug resistance, adverse effects, and limited access in developing nations.
- Herbal natural products offer potential as sources for novel anti-HIV drugs targeting various life cycle stages.
Purpose of the Study:
- To investigate the anti-HIV-1 activity of aqueous dandelion extract.
- To evaluate the impact of dandelion extract on HIV-1 replication and reverse transcriptase activity.
Main Methods:
- Utilized pseudotyped HIV-1 virus to assess anti-HIV-1 activity.
- Measured HIV-1 replication by quantifying GFP-positive cells.
- Assessed reverse transcriptase activity using a standard assay kit.
Main Results:
- Dandelion extract significantly decreased HIV-1 replication in a dose-dependent manner.
- Reverse transcriptase activity was inhibited by the dandelion extract, also in a dose-dependent manner.
- The extract demonstrated potent inhibitory effects against HIV-1 replication and reverse transcriptase.
Conclusions:
- Dandelion extract exhibits strong activity against HIV-1 reverse transcriptase (RT).
- The extract inhibited replication of both HIV-1 vectors and hybrid retroviruses.
- Taraxacum officinale extracts represent a promising starting point for developing antiretroviral therapies with potentially fewer side effects.
